There are no approved vaccines or treatments for Sudan virus disease, which has a 40–70% fatality rate. To curb the ongoing outbreak, Uganda has deployed—under a clinical trial setting—a vaccine ...

The Sudan virus, a close relative of Ebola, has a fatality rate of 50% but remains poorly understood in terms of how it ...

A new study finds that the Sudan virus, a deadly Ebola relative, binds to human NPC1 receptors with nine times greater ...

Makerere University, the Uganda Virus Research Institute and the WHO got the Uganda Ebola vaccine trial ready for dosing in ...

Lange's study revealed that the most common ancestor of Zaire ebolavirus was circulating in the forests of what is now the ...

Sudan virus (SUDV) can infect people to cause Sudan virus disease (SVD). Right now, an outbreak of SVD has been detected in ...

WHO and the Uganda Health Ministry have launched a first-ever vaccine trial for the species of Ebola at the center of an ongoing outbreak in Uganda’s capital city.

Ebola is rare, deadly and has multiple variations. There is a vaccine for the Zaire type, now trials for another are underway ...

This is a critical achievement toward better pandemic preparedness and saving lives when outbreaks occur,” said Dr. Tedros ...

In a global first, Uganda's Ministry of Health, the World Health Organization (WHO) and other partners today launched a first ever vaccine trial for Ebola from the Sudan species of the virus, and at ...